Knight Therapeutics Inc.
GUD.TOTSXHealthcare● Active
$9.14
+$0.53(+6.16%)
Market Cap$896037158
P/E Ratio—
52W High$9.25
52W Low$5.66
Knight Therapeutics Inc. (GUD.TO) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · GUD.TO · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.10B | $0.17B | $0.15B | $0.19B | $0.16B |
| Net Receivables | $0.14B | $0.11B | $0.10B | $0.11B | $0.07B |
| Inventory | $0.14B | $0.10B | $0.09B | $0.09B | $0.07B |
| Total Current Assets | $0.39B | $0.40B | $0.37B | $0.40B | $0.31B |
| PP&E Net | $0.02B | $0.02B | $0.02B | $0.02B | $0.03B |
| Goodwill | $0.09B | $0.09B | $0.08B | $0.08B | $0.08B |
| Intangible Assets | $0.38B | $0.28B | $0.29B | $0.34B | $0.35B |
| Total Assets | $1.05B | $0.96B | $0.95B | $1.05B | $0.99B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.02B | $0.02B | $0.02B | $0.03B |
| Accounts Payable | $0.12B | $0.08B | $0.09B | $0.11B | $0.07B |
| Total Current Liabilities | $0.17B | $0.11B | $0.11B | $0.14B | $0.11B |
| Long-Term Debt | $0.05B | $0.03B | $0.04B | $0.05B | $0.01B |
| Total Liabilities | $0.28B | $0.17B | $0.20B | $0.23B | $0.15B |
| Stockholders Equity | |||||
| Retained Earnings | $0.15B | $0.15B | $0.15B | $0.16B | $0.19B |
| Total Stockholders Equity | $0.77B | $0.80B | $0.75B | $0.83B | $0.84B |
| Total Liab & Equity(computed) | $1.05B | $0.96B | $0.95B | $1.05B | $0.99B |
| Debt Summary | |||||
| Total Debt | $0.08B | $0.05B | $0.07B | $0.08B | $0.04B |
| Net Debt | $0.00B | ($0.03B) | $0.01B | $0.01B | ($0.05B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · CAD · B
Explore more Knight Therapeutics Inc. data
About Knight Therapeutics Inc. (GUD.TO) Balance Sheet
Knight Therapeutics Inc. (GUD.TO) balance sheet shows total assets of $1.05B with cash of $0.10B. Total liabilities are $0.28B, total debt $0.08B, and stockholders equity $0.77B.
Frequently asked questions
GUD.TO · 4 questionsKnight Therapeutics Inc. has total debt of $0.08B with net debt of $0.00B.
GUD.TO total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10